Profile of evolocumab and its potential in the treatment of hyperlipidemia

Despite the proven efficacy of statins, they often fail to achieve low-density lipoprotein (LDL) cholesterol goals, especially in high-risk patients. Moreover, a large number of subjects cannot tolerate statins or full doses of these drugs, in particular patients with familial hypercholesterolemia....

Descripción completa

Detalles Bibliográficos
Autores principales: Cicero, Arrigo FG, Colletti, Alessandro, Borghi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474387/
https://www.ncbi.nlm.nih.gov/pubmed/26109850
http://dx.doi.org/10.2147/DDDT.S67498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474387/
https://www.ncbi.nlm.nih.gov/pubmed/26109850
http://dx.doi.org/10.2147/DDDT.S67498

Ejemplares similares